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N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels highly
permeable to calcium and essential to excitatory neurotransmission. The NMDARs have
attracted much attention because of their role in synaptic plasticity and excitotoxicity.
Evidence has recently accumulated that NMDARs are negatively regulated by intracellular
calcium binding proteins. The calcium-dependent suppression of NMDAR function
serves as a feedback mechanism capable of regulating subsequent Ca2+ entry into the
postsynaptic cell, and may offer an alternative approach to treating NMDAR-mediated
excitotoxic injury. This short review summarizes the recent progress made in
understanding the negative modulation of NMDAR function by DREAM/calsenilin/KChIP3,
a neuronal calcium sensor (NCS) protein.
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INTRODUCTION
Glutamate functions as the major excitatory neurotransmitter by
binding to N-methyl-D-aspartate receptors (NMDARs) that are
widespread in the central nervous system. The NMDARs consti-
tute a major class of ionotropic glutamate receptors and play an
essential role in synaptic transmission, plasticity, and memory.
Activation of NMDARs results in cell membrane depolarization
with an equilibrium potential near 0mV, producing the excita-
tory postsynaptic potential (EPSP) and leading to an increase
of Ca2+ influx into the cell. The intracellular Ca2+ can in turn
function as a second messenger, mediating a variety of signaling
cascades. Excessive activation of NMDARs by glutamate medi-
ates neuronal damage in many neurological disorders including
ischemia and neurodegenerative diseases (Choi et al., 1988; Sattler
and Tymianski, 2001).
The NMDARs have long been considered the main target for
the treatment of excitotoxicity-related neuronal injury, and a vari-
ety of antagonists or blockers of NMDARs have been developed.
Unfortunately, the results of clinical trials have been disappoint-
ing because of the obvious side effects associated with blocking
the physiological roles of NMDARs (Chen and Lipton, 2006).
Therefore, a better understanding of the mechanism of how
NMDARs can be modulated by regulatory proteins should help in
the development of new therapeutic agents to counteract overac-
tive NMDA receptor function, andmay represent an alternative to
treating NMDAR-mediated excitotoxic injury. This short review
focuses on the specific negative modulation of NMDARs by
a neuronal calcium sensor (NCS) protein, DREAM/calsenilin/
KChIP3.
STRUCTURAL AND FUNCTIONAL FEATURES OF NMDA
RECEPTOR CHANNELS
NMDARs are believed to be heterotetrameric complexes com-
posed of combinations of the obligatory NR1 subunit and NR2
and/or NR3 subunits (Chazot and Stephenson, 1997; Laube et al.,
1998; Schorge and Colquhoun, 2003; Furukawa et al., 2005).
The NR1 subunit is encoded by a single gene but exists as eight
functional splice variants, while the NR2 (NR2A-B) and NR3
(NR3A-B) subunits are encoded by four and two different genes,
respectively. The NMDAR subunits form a central ion conduc-
tance pathway selective for cations such as Na+, K+, and Ca2+,
and share a commonmembrane topology, with each subunit con-
sisting of four transmembrane (TM) domains (M1–M4). The
long extracellular N-terminal regions of NMDAR subunits are
organized as a tandem of two domains. The first domain, called
the N-terminal domain (NTD) that includes the first 380 amino
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acids, is involved in tetrameric assembly (Mayer, 2006; Paoletti
and Neyton, 2007; Stroebel et al., 2011). The second domain of
about 300 amino acids is known as the agonist-binding domain
(ABD) that precedes the TM1 domain. The ABD binds glycine
(or D-serine) in the NR1 and NR3 subunits, whereas the NR2
ABD binds glutamate (Furukawa et al., 2005; Yao and Mayer,
2006). The pore loop (P loop), or the M2 region, forms the
narrowest constriction of the channel ion conductance path-
way and determines the permeation properties of NMDARs.
The NMDARs feature an intracellular C-terminal tail of about
400–600 residues that has a strong diversity in its amino acid
sequence. The C-terminal tails of NMDAR subunits contain a
series of short motifs that interact with intracellular factors or
binding partners involved in receptor trafficking, anchoring and
signaling (Skeberdis et al., 2006; Ryan et al., 2008; Lau et al., 2010).
Activation of NMDARs requires a simultaneous binding of
two co-agonists, glutamate, and glycine with different biophysi-
cal properties of ion permeation. The typical NMDARs contain
NR2 subunits with properties of high permeability to Ca2+ and
extracellular Mg2+ block at hyperpolarized membrane potentials
(Wrighton et al., 2008; Singh et al., 2012). Different from con-
ventional NR1/NR2 heterotetramers, NR3-containing NMDARs
have unique properties with a five to tenfold decrease of Ca2+
permeability, insensitivity to Mg2+ block, and reduced single-
channel conductance and open probability, functioning as a neg-
ative modulator for NMDA receptor channel function (Das et al.,
1998; Sasaki et al., 2002; Nakanishi et al., 2009; Cavara et al., 2010;
Henson et al., 2010).
MODULATION OF NMDAR FUNCTION BY INTRACELLULAR
BINDING PARTNERS
NMDAreceptorsarealsoregulatedbyotherintracellularsignalsand
proteins, including calcium, protein kinases, protein phosphatase
calcineurin, and calcium-sensitive proteins such as calmodulin
(Legendre et al., 1993; Vyklicky, 1993; Lieberman andMody, 1994;
Tong et al., 1995; Ehlers et al., 1996). Calcium-dependent NMDA
receptor desensitization and inactivation provides a feedback
mechanism capable of regulating subsequent Ca2+ entry into
the postsynaptic cell through NMDA channels (Figure 1).
So far, a number of NR1 or NR2 subunit binding partners
have been identified in the postsynaptic density. The NR1 bind-
ing proteins include calmodulin (CaM) (Ehlers et al., 1996;
Akyol et al., 2004), Ca2+/CaM-dependent protein kinase II
(CaMKII) (Leonard et al., 2002), α-actinin (Wyszynski et al.,
1997; Merrill et al., 2007), tubulin (van Rossum et al., 1999),
spectrin (Wechsler and Teichberg, 1998), neurofilament (Ehlers
et al., 1998), and Yotiao (Lin et al., 1998). Calmodulin bind-
ing to the NR1 subunit is Ca2+ dependent and occurs with
homomeric NR1 complexes, heteromeric NR1/NR2 subunit
complexes from expression systems, and NMDA receptors from
the brain. Calmodulin binding to NR1 causes a fourfold reduc-
tion in NMDA channel open probability, mediating the negative
modulation of NMDAR function (Ehlers et al., 1998).
DREAM/calsenilin/KChIP3, A NEURONAL CALCIUM
SENSOR AND CALCIUM BINDING EF-HAND PROTEIN
DREAM/calsenilin/KChIP3 is encoded by the same gene locus.
The downstream regulatory element antagonist modulator
(DREAM) protein, first identified in the nucleus as a Ca2+-
regulated transcriptional repressor through its binding to DNA
at specific regulatory elements, contains four Ca2+-binding EF-
hand domains and belongs to the NCS family (Carrion et al.,
1999; Burgoyne, 2007). DREAMwas named for its ability to block
gene expression in its Ca2+-free form via direct binding with
the downstream regulatory element (DRE) sequence in target
genes such as preprodynorphin (PPD), c-fos, Hrk, Na+, and Ca2+
exchanger NCX3 (Carrion et al., 1999; Sanz et al., 2001; Gomez-
Villafuertes et al., 2005). DREAMwas also named calsenilin or Kv
channel interacting protein 3 (KChIP3) (Buxbaum et al., 1998;
An et al., 2000), indicating that DREAM/calsenilin/KChIP3 has
multifunctional properties. In the nucleus the DREAM protein
functions as a dimer, whereas outside the nucleus KChIP3 is a
monomer and regulates the surface expression and gating kinet-
ics of Kv4 channels (An et al., 2000; Kim and Sheng, 2004;
FIGURE 1 | Schematic representation for inhibitory effect of
DREAM/calsenilin/KChIP3 on NMDARs in a Ca2+-sensitive manner.
Upon activation of NMDARs by glutamate binding, Ca2+ influx through
NMDARs increases the association between DREAM and NR1 subunits,
resulting in reduced surface expression of NMDARs, and subsequent
inhibition of NMDARs-mediated Ca2+ influx and excitotoxicity. DREAM
functions as a Ca2+-sensitive modulator for the negative feedback control of
NMDAR function.
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Scannevin et al., 2004; Pioletti et al., 2006; Wang et al., 2007;
Wang, 2008).
DREAM/calsenilin/KChIP3 is preferentially expressed in the
central nervous system, as well as in non-neuronal tis-
sues (Link et al., 2004; D’Andrea et al., 2005; Savignac
et al., 2005). DREAM/calsenilin/KChIP3 knock-out mice dis-
play a hypoalgesic phenotype, suggesting a critical role of
DREAM/calsenilin/KChIP3 in pain modulation (Cheng et al.,
2002). In addition, emerging evidence reveals the role of
DREAM/calsenilin/KChIP3 in long-term potentiation (LTP)
(Lilliehook et al., 2003) and learning and memory (Alexander
et al., 2009; Fontan-Lozano et al., 2009), suggesting a possible
connection between DREAM and NMDA function.
KChIP1–3 were initially identified from a rat brain library
in yeast two-hybrid (YTH) screens using the cytoplasmic
N-terminal domain (amino acids 1–180) of rat Kv4.3 as a bait
(An et al., 2000). Similarly, KChIP4 from mouse and human
was accidentally cloned using the C-terminal 43 amino acid
residues of presenilin 2 (PS2, amino acids 406–448) as a bait in
the YTH system (Morohashi et al., 2002). KChIP4, also known
as calsenilin-like protein (CALP), binds to PS2 which is known
to facilitate intramembranous γ-cleavage of γ-amyloid protein
precursor (βAPP) (Morohashi et al., 2002).
KChIP1–4 (216 ∼ 256 amino acids) can co-immuno-
precipitate and co-localize with either Kv4 from co-transfected
cells or Kv4 α-subunits from tissues, and thus constitute integral
components of native Kv4 channel complexes (Wang, 2008).
KChIP1–4 all share a conserved carboxy-terminal core region that
contains four EF-hand-like calcium binding motifs, but have a
variable amino-terminal region that causes diverse modulation of
Kv4 trafficking and channel function (An et al., 2000; Holmqvist
et al., 2002; Scannevin et al., 2004; Cui et al., 2008; Liang et al.,
2009, 2010).
FUNCTIONAL INTERACTIONS BETWEEN DREAM AND
NMDA RECEPTORS
We and others have investigated mechanisms underlying the
functional interactions between DREAM andNMDARs. Findings
from co-immunoprecipitation experiments show that DREAM
antibody can immunoprecipitate endogenous NR1 subunit and
DREAM protein from rat hippocampal tissue (Zhang et al.,
2010). In the reciprocal co-IP studies in HEK 293 cells express-
ing DREAM andNR1-1a (NR1a) proteins, NR1 antibody can also
immunoprecipitate DREAM along with the NR1 subunit. GST
pull-down assays reveal that the N-terminus of DREAM directly
interacts with the NR1a C-terminus, and that the DREAM-NR1
interaction is sensitive to Ca2+ and depends on the EF hand
domains of DREAM (Zhang et al., 2010).
PSD-95 is a major scaffolding protein in the postsynaptic
density, tethering NMDARs to signaling proteins, and is criti-
cal for NMDA receptor function (Kim and Sheng, 2004). Wu
et al. generated a line of transgenic mice (TgDREAM) over-
expressing a dominant active DREAM mutant, and compared
NMDA receptor-mediated EPSCs in TgDREAM and wild-type
mice under conditions of various stimulation intensities (Wu
et al., 2010). They found that the amplitude of NMDA receptor-
mediated EPSCs in TgDREAM mice is significantly reduced
compared to that in wild-type mice (Wu et al., 2010). In addi-
tion, LTD is significantly reduced in TgDREAMmice whereas LTP
is not affected by DREAM, demonstrating that DREAM inter-
acts with PSD-95, and that the interaction is negatively regulated
by calcium (Wu et al., 2010). In Xenopus oocytes expressing
NR2B-containing NMDARs alone or together with DREAM,
two-electrode voltage clamp recordings show that, in the absence
of DREAM, the peak currents of NMDA channels activated by
glutamate (plus glycine) are suppressed by DREAM, and the cur-
rent decrease is caused by a reduction in the density of NMDARs
at the cell surface (Figure 1; Zhang et al., 2010).
Fontan-Lozano et al. recently provided another piece of evi-
dence that DREAM negatively regulates the function of NMDA
receptors (Fontan-Lozano et al., 2011). By taking advantage of
mice lacking the DREAM protein, they demonstrated that the
facilitated learning induced by decreased expression of Kv4.2
in dream−/− mice requires the activation of NMDA recep-
tors containing the NR2B subunit (Fontan-Lozano et al., 2011).
This study not only indicates the significance of the bal-
ance between Kv4 channel function and NMDAR activity, but
also suggests the formation of a functional complex between
DREAM/Kv4.2/NMDARs that regulates the synaptic efficacy
mediating synaptic plasticity and learning.
NEUROPROTECTIVE EFFECT OF DREAM/calsenilin/KChIP3
OVER-EXPRESSION ON NEURONAL EXCITOTOXIC INJURY
Excitotoxicity is caused by overactivation of NMDA receptor
function, and inhibition of NMDARs can reverse the neu-
ronal toxicity. The data available so far support both the pro-
apoptotic and anti-apoptotic roles of DREAM. In general, the
pro-apoptotic role of DREAM closely correlates with its interac-
tion with presenilins, the production of amyloid beta (Aβ) and
the modulation in Ca2+ signaling, whereas the anti-apoptotic
role of DREAM is conferred by its transcriptional repressor activ-
ity on the apoptotic protein Hrk. Jo et al. reported that HeLa
cells transiently transfected with DREAM exhibit the morpho-
logical and biochemical features of apoptosis and that expression
of presenilin potentiates DREAM-induced apoptosis (Jo et al.,
2001). Jo et al. also reported that DREAM expression increases
in either human neuroblastoma SK-N-BE2(c) cells or rat neu-
roblastoma B103 cells after exposure to Aβ, but no other apop-
totic inducers such as staurosporine, thapsigargin, and calcium
ionophore A23187. The pro-apoptotic role of DREAM is selec-
tively induced during Ab toxicity. Because of the involvement
of presenilins/γ-secretase in Aβ formation and neuronal death,
DREAM coordinates with presenilin activity to play a crucial role
in these processes through binding with the C-terminus of pre-
senilins (Jo et al., 2003, 2004). Lilliehook et al. stably expressed
DREAM in H4 neuroglioma cells which showed no initiation of
apoptosis in the absence of apoptosis triggers, and the apoptosis-
associated caspase and calpain activities were not affected by
DREAM (Lilliehook et al., 2002). On the other hand, binding
of the transcriptional repressor DREAM to the hrk gene avoids
inappropriate Hrk expression and apoptosis in hematopoietic
progenitor cell lines (Sanz et al., 2001, 2002). Nevertheless, the
precise function of DREAM in pro-apoptosis and anti-apoptosis
remains to be explored.
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From our previous observations, we noticed that cell viabil-
ity is affected by the amount of exogenous DREAM gene and
the method of transfection. However, we could not observe
any obvious morphological changes associated with cell death
after the transfection of DREAM. To prove the cytoprotective
role of DREAM, we utilized cell lines and primary cultured
hippocampal neurons with DREAM overexpression or siRNA-
mediated knockdown, and evaluated lactate dehydrogenase
(LDH) leakage and propidium iodide (PI) uptake both in
NMDA and oxygen-glucose deprivation (OGD) -induced exci-
totoxic injury models (Zhang et al., 2010). Administration
of NMDA markedly increases the number of PI-positive cells
(dead cells) in NMDAR-transfected CHO cells, whereas co-
expression of DREAM greatly reduces PI-positive cells (Zhang
et al., 2010). LDH leakage measurement is a sensitive index
reflecting the extent of cell damage. Over-expression of DREAM
suppresses the NMDA-induced LDH release. OGD is com-
monly used in vitro to mimic ischemia-reperfusion insult to
the brain, and OGD treatment induces a significant increase
of LDH release (Dawson et al., 1994). With over-expression of
DREAM, however, OGD treatment induces a smaller increase
in LDH release. These results indicate that the over-expression
of DREAM attenuates NMDAR-mediated excitotoxicity
(Zhang et al., 2010).
We have previously tested the effect of DREAM siRNA on
NMDA-induced current and excitotoxic injury in hippocampal
neurons (Zhang et al., 2010). Knockdown of endogenous
DREAM with siRNA results in an increased amplitude of NMDA
current recorded by whole-cell patch-clamp assays. DREAM
siRNA also significantly exacerbates NMDA-induced cell death in
hippocampal neurons. After NMDA exposure, PI-positive cells in
the DREAM siRNA group increase compared with control siRNA,
indicating the inhibitory effect of DREAM on NMDAR-mediated
current and excitotoxic injury (Zhang et al., 2010).
CONCLUSIONS
The NCS protein DREAM/calsenilin/KChIP3 acts as an auxiliary
subunit and suppresses NMDA receptor channel function. This
negative modulation of NMDA receptor function by DREAM
likely provides a feedbackmechanism by which overactive NMDA
receptors are inhibited. Therefore, targeting regulatory pro-
teins of NMDARs may represent an alternative approach to
treating NMDAR-mediated excitotoxic damage and providing
neuroprotection.
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